Bottles for the Pfizer BioNTech COVID-19 vaccine are ready to be prepared before the opening of a mass vaccination site in the Queens borough of New York, February 24, 2021.
Seth Wenig | Pool | Reuters
Pfizer CEO Albert Bourla said Tuesday that his company has ramped up production of its two-shot vaccine and will be able to deliver a total of 300 million doses to the U.S. ahead of schedule.
Bourla said Pfizer can deliver 10% more doses to the U.S. by the end of May than it had previously agreed to produce. The company will be able to the full 300 million to the U.S. two weeks early, he said.
This is breaking news. Please check back for updates.